IPC is a not-for-profit company managed by a Board.  Company Directors are drawn from the health sector, local community and the University of Queensland.  All have management qualifications and experience, with most being members of the Australian Institute of Company Directors.

Dr John Aloizos AM has been the independent Chairman since 2007.  Local federal member, The Hon. Bernie Ripoll MP also plays an active role in the company.  They are joined Mr Eugene McAteer who has active links with Queensland Health and the Greater South Brisbane Medicare Local.

A Finance, Audit and Risk Sub-Committee oversees budget, reporting, compliance, ICT, and HR issues.  Annual diagnostics and comparative benchmarks of performance have been implemented to ensure IPC delivers best practice across all areas of its business.

A Clinical Governance Sub-Committee defines IPC’s research and clinical delivery priorities and approves any new research projects or clinical services.  It also reviews the teaching program, any serious adverse events or near misses and recommends the clinical staffing complement and professional development needs of the business.

Feeding into the Clinical Governance Sub-Committee is the IPC Grand Rounds process.  This monthly meeting of medical staff completes reviews of patient safety related events, adjudicates on new clinical protocols to be adopted within the facility and provides a collegiate, evidence based environment for discussing complex cases.

 

Annual consultations with patients and surrounding medical practices, along with interrogation of the IPC database, generate ideas for new services.  The medical and nursing team reports will evolve over the next 12 months to include indicators related to conformity with cycles of care, nationally agreed clinical pathways and internal clinical protocols.  These new indicators will be used to direct attention to business and clinical systems and education required to ensure patient outcomes, even in instances of co-morbidity, deliver health outcomes the envy of other clinical settings.